Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estrogen in Alzheimer's Disease
NCT00018343Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Apr 1998
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Alzheimer's disease (AD) comparing Estrogen with Placebo (2 arms). Primary endpoint: Cognitive Function (Memory, Attention) at 8 weeks. Started Apr 1998; status: completed.
02
Drugs
estradiol
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00018343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018343.